Perrigo set to launch Clarinex generic
Perrigo Co. has gained final approval from the Food and Drug Administration for desloratadine tablets (5 mg), an allergy medication.
CDR
Walgreens brings new format to D.C.
Walgreen Co.’s new "health and daily living store" concept has made its debut in Washington, D.C., and the drug chain plans more of the new-format stores in that market.
SDM, Katz lose in court on private-label generics
In a setback for Canadian drug store chains, the Ontario government has won an appeal to reinstate a ban on private-label generic drugs in the province.
Pharmacy techs serve up FSA advice
Retail pharmacy teams, including pharmacy technicians, are offering practical solutions to patients about how to best use remaining 2011 flexible spending account (FSA) funds, according to the Pharmacy Technician Certification Board (PTCB).
CutisPharma expands mouthwash compounding kit line
CutisPharma Inc. has extended its FIRST Magic Mouthwash line with four- and six-ounce BLM compounding kits.
Amneal rolls out generic Felbamate suspension
Amneal Pharmaceuticals has launched what it said is the first generic Felbamate oral suspension in 600 mg/5 ml strength. Amneal said Wednesday that the first-to-market product is an AB-rated, therapeutically equivalent alternative to Meda Pharmaceuticals’ Felbatol.
Walgreens stands firm in quarrel with PBM
With no resolution imminent in its stand-off with Express Scripts Inc., Walgreen Co. said it’s prepared to take a short-term hit rather than digest the long-term consequences of accepting the pharmacy benefit manager’s contract proposal.
MinuteClinic enters first clinical affiliation in Mass.
MinuteClinic has entered into a clinical collaboration with UMass Memorial Health Care, the largest health care system in central and western Massachusetts and the clinical partner of the University of Massachusetts Medical School.
PuraMed readies launch of migraine treatment
PuraMed BioScience Inc. is hatching plans for the national product launch of LipiGesic M, its clinically tested migraine headache treatment.
Medco shareholders OK Express Scripts merger
Medco Health Solutions Inc. shareholders have approved the company’s proposed merger with Express Scripts Inc.
Earnings at Walgreens tail off in first quarter
Net earnings slipped at Walgreen Co. in its fiscal 2012 first quarter as the drug chain cited its contract impasse with Express Scripts Inc., a slow cough/cold and flu season, and a tough year-over-year comparison as impacting results. Walgreens said Wednesday that for the first quarter ended Nov.
Prestige Brands to buy 17 OTC brands from GSK
Prestige Brands Holdings Inc. plans to acquire 17 over-the-counter pharmaceutical brands sold in North America from GlaxoSmithKline in $660 million cash deal.
Amgen, Watson team on oncology biosimilars
Amgen and Watson Pharmaceuticals Inc. plan to collaborate on the development and global commercialization of several oncology antibody biosimilar medicines.
CVS executives tout ‘unique suite of assets’
At its Analyst Day event in New York, CVS Caremark Corp. projected robust earnings and revenue growth for fiscal 2012 as executives cited health care trends that bode well for the company’s integrated business model, which combines a retail drug chain and pharmacy benefit management unit.
Bi-Lo set to merge with Winn-Dixie
Bi-Lo LLC and Winn-Dixie Stores Inc. have agreed to merge in a deal that stands to create a food and drug chain of nearly 690 stores in eight southeastern states. Under the merger agreement announced Monday, Bi-Lo plans to acquire all outstanding shares of Winn-Dixie stock for about $560 million.
Analyst Day Preview: CVS is well-positioned
Financial analysts are showing renewed faith in CVS Caremark Corp.’s integrated business model. Operating a retail drug store chain and a pharmacy benefit manager (PBM), the company is well-positioned to prosper amid recent shifts in the pharmacy sector, according to analysts.